When: Thursday, May 23, 2024           12:00 pm -1:00 pm EDT

Featured Trial

(CHUQ) BicaBCa: A phase II randomized trial of bicalutamide in patients receiving intravesical BCG for non-muscle invasive bladder cancer (NCT05327647)

Speaker: Dr. Paul Toren, MD, Associate Professor, Department of Surgery – Faculty of Medicine, Université Laval

Speaker: Dr. Joe Pater, MD, Emeritus Professor, Queen’s University & Portfolio Sub-Committee Chair, 3CTN

This session will provide participants the opportunity to gain valuable insights on the peer review process for clinical trials and engage directly with the Portfolio Chair. Learn more about:

  • The importance of peer review.
  • How peer reviewers assess the scientific merit and feasibility of study protocols.

Register Here

Tags:

Posted on: